96 related articles for article (PubMed ID: 10087988)
1. Commentary: low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease.
Elstein D; Abrahamov A; Itzchaki M; Zimran A
Blood Cells Mol Dis; 1998 Sep; 24(3):303-5; discussion 306-8. PubMed ID: 10087988
[No Abstract] [Full Text] [Related]
2. Low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease.
Cohen IJ; Katz K; Kornreich L; Horev G; Frish A; Zaizov R
Blood Cells Mol Dis; 1998 Sep; 24(3):296-302. PubMed ID: 10087987
[TBL] [Abstract][Full Text] [Related]
3. Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy.
Sidransky E; Ginns EI; Westman JA; Ehmann WC
Am J Hematol; 1994 Nov; 47(3):247-9. PubMed ID: 7942798
[No Abstract] [Full Text] [Related]
4. [Gaucher disease with multiple bone necrosis treated by enzyme replacement therapy and pamidronate].
Abe M; Minoguchi M; Jinbo J; Kikuchi Y; Chiba A; Shibata Y; Kogo Y
Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2421-3. PubMed ID: 15624481
[No Abstract] [Full Text] [Related]
5. Gaucher's disease.
Lachiewicz PF
Orthop Clin North Am; 1984 Oct; 15(4):765-74. PubMed ID: 6493737
[TBL] [Abstract][Full Text] [Related]
6. Progression of bone disease without deterioration of hematological parameters in a child with Gaucher disease during low-dose glucocerebrosidase therapy.
Migita M; Fukunaga Y; Ueda T; Watanabe A; Morita T; Yamamoto M
Nihon Ika Daigaku Zasshi; 1994 Nov; 61(6):633-7. PubMed ID: 7829657
[TBL] [Abstract][Full Text] [Related]
7. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
[No Abstract] [Full Text] [Related]
8. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
Cleary JE; Burke WM; Baxi LV
Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
[TBL] [Abstract][Full Text] [Related]
9. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Hachulla E; Javier RM
Rev Med Interne; 2007 Oct; 28 Suppl 2():S180-2. PubMed ID: 18228685
[No Abstract] [Full Text] [Related]
10. Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.
Lebel E; Elstein D; Peleg A; Reinus C; Zimran A; Amir G
Am J Clin Pathol; 2013 Jul; 140(1):91-6. PubMed ID: 23765538
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of painful bone crises in type I gaucher's disease with high dose prednisolone.
Cohen IJ; Kornreich L; Mekhmandarov S; Katz K; Zaizov R
Arch Dis Child; 1996 Sep; 75(3):218-22. PubMed ID: 8976661
[TBL] [Abstract][Full Text] [Related]
12. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
Mistry PK; Deegan P; Vellodi A; Cole JA; Yeh M; Weinreb NJ
Br J Haematol; 2009 Nov; 147(4):561-70. PubMed ID: 19732054
[TBL] [Abstract][Full Text] [Related]
13. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
Charrow J; Dulisse B; Grabowski GA; Weinreb NJ
Clin Genet; 2007 Mar; 71(3):205-11. PubMed ID: 17309642
[TBL] [Abstract][Full Text] [Related]
14. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Javier RM; Hachulla E
Presse Med; 2007 Dec; 36(12 Pt 3):1971-84. PubMed ID: 17498916
[TBL] [Abstract][Full Text] [Related]
15. Using the International Gaucher Disease Registry data: can we devise a virtuous circle for treated patients?
Elstein D; Zimran A
Am J Hematol; 2008 Dec; 83(12):887-9. PubMed ID: 18980272
[No Abstract] [Full Text] [Related]
16. The effect of enzyme therapy in a patient with Gaucher disease type III.
Bosman DK; Hollak CE; Aerts JM; Bakker HD
J Inherit Metab Dis; 1996; 19(5):703-4. PubMed ID: 8892032
[No Abstract] [Full Text] [Related]
17. Therapeutic goals in Gaucher disease.
Mistry P; Germain DP
Rev Med Interne; 2006 Mar; 27 Suppl 1():S30-8. PubMed ID: 16644400
[TBL] [Abstract][Full Text] [Related]
18. Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy.
Camou F; Viallard JF
Blood Cells Mol Dis; 2012 Jan; 48(1):51-2. PubMed ID: 21983348
[No Abstract] [Full Text] [Related]
19. Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.
Czartoryska B; Tylki-Szymańska A; Lugowska A
Clin Biochem; 2000 Mar; 33(2):147-9. PubMed ID: 10751594
[No Abstract] [Full Text] [Related]
20. Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT).
Giona F; Palumbo G; Amendola A; Santoro C; Mazzuconi MG
J Thromb Haemost; 2006 Aug; 4(8):1831-3. PubMed ID: 16879228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
